Загрузка...
Translational and Early Phase Strategies for Treatment Development: Report of ISCTM Autumn 2013 Symposium
For decades, there has been a distinct disconnect translating a compound’s effects from basic neuroscience into clinical efficacy. This disconnect has not only been in terms of generating approved compounds, but also in rejecting targets. During the drug discovery process there are key points to be...
Сохранить в:
| Опубликовано в: : | Innov Clin Neurosci |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Matrix Medical Communications
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4571292/ https://ncbi.nlm.nih.gov/pubmed/25977839 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|